🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

LONGitudinal Multi-omics Phenotyping of KIDney Function Alteration

Recruitingn/aAges 18 Years - 75 YearsAllCharite University, Berlin, Germany
NCT05570929 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a longitudinal observation of kidney function, immune system and gut microbiota before and 24 weeks after a live kidney transplantation conducted in donor and recipient pairs living in the same household. Outcome measures include kidney function, body composition, blood pressure, gut microbiome composition, metabolomics and immune cell states.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Body-Mass-Index 18,5 - 34,9 kg/m2 * Planned living kidney donation / transplantation Exclusion Criteria: * Clinically relevant heart, lung, liver, and kidney diseases * Postoperative phase * Acute infections * Vegan diet * Change of body weight of more than 10% in the month prior to study entry * Known drug or alcohol abuse
💊

What it tests

  • Not listed
📍

Where

1 site
Experimental and Clinical Research Center
Berlin, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy